Genetic Associations with Diabetes: Meta-Analyses of 10 Candidate Polymorphisms

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Tang, Linlin ^a   Wang, Lingyan ^b   Liao, Qi ^a   Wang, Qinwen ^a   Xu, Leiting ^a   Bu, Shizhong ^a   Huang, Yi ^a   Zhang, Cheng ^a   Ye, Huadan ^a   Xu, Xuting ^a   Liu, Qiong ^a   Ye, Meng ^a   Mai, Yifeng ^a   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b NINGBO NO 2 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; APOA5 GENE; ARTICLE; ATF6 GENE; BIBLIOGRAPHIC DATABASE; CASQ1 GENE; CLEC16A GENE; DIABETES MELLITUS; DISEASE PREDISPOSITION; ETHNIC GROUP; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GNB3 GENE; HUMAN; IL12B GENE; IL2RA GENE; INSULIN DEPENDENT DIABETES MELLITUS; KLF11 GENE; NLRP1 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SLC2A10 GENE; SYSTEMATIC REVIEW;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84880826338     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070301     Document Type: Article

References (86)

1. WHO (2011) Burden: mortality, morbidity and risk factors- Chapter 1 of the latest WHO report "Global status report on NCDs 2010".
2. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, et al. (2013) Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339: 1084-1088.
3. Ashcroft FM, Rorsman P, (2012) Diabetes mellitus and the beta cell: the last ten years. Cell 148: 1160-1171.
4. Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J, (2003) Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52: 1052-1055.
5. Jenkins AB, Samaras K, Carey DG, Kelly P, Campbell LV, (2000) Improved indices of insulin resistance and insulin secretion for use in genetic and population studies of type 2 diabetes mellitus. Twin Res 3: 148-151.
6. Wang X, Ding X, Su S, Spector TD, Mangino M, et al. (2009) Heritability of insulin sensitivity and lipid profile depend on BMI: evidence for gene-obesity interaction. Diabetologia 52: 2578-2584.
7. Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, et al. (2005) Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 54: 275-283.
8. Beck-Nielsen H (1999) General characteristics of the insulin resistance syndrome: prevalence and heritability. European Group for the study of Insulin Resistance (EGIR). Drugs 58 Suppl 1: 7-10; discussion 75-82.
9. Huyghe JR, Jackson AU, Fogarty MP, Buchkovich ML, Stancakova A, et al. (2013) Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion. Nat Genet 45: 197-201.
10. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, et al. (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44: 981-990.
11. Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, et al. (2012) A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 44: 659-669.
12. Cho YS, Chen CH, Hu C, Long J, Ong RT, et al. (2012) Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 44: 67-72.
13. Kim HP, Imbert J, Leonard WJ, (2006) Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev 17: 349-366.
14. Tschopp J, Martinon F, Burns K, (2003) NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 4: 95-104.
15. Trinchieri G, (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13: 251-276.
16. Zoledziewska M, Costa G, Pitzalis M, Cocco E, Melis C, et al. (2009) Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia. Genes Immun 10: 15-17.
17. Lanner JT, Katz A, Tavi P, Sandstrom ME, Zhang SJ, et al. (2006) The role of Ca2+ influx for insulin-mediated glucose uptake in skeletal muscle. Diabetes 55: 2077-2083.
18. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, et al. (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169-173.
19. Zhang H, Chen Q, Yang M, Zhu B, Cui Y, et al. (2012) Mouse KLF11 regulates hepatic lipid metabolism. J Hepatol.
20. Back SH, Kang SW, Han J, Chung HT, (2012) Endoplasmic reticulum stress in the beta-cell pathogenesis of type 2 diabetes. Exp Diabetes Res 2012: 618396.
21. Chang L, Chiang SH, Saltiel AR, (2004) Insulin signaling and the regulation of glucose transport. Mol Med 10: 65-71.
22. Fichna M, Zurawek M, Fichna P, Januszkiewicz D, Nowak J, (2012) Polymorphic variants of the IL2RA gene and susceptibility to type 1 diabetes in the Polish population. Tissue Antigens 79: 198-203.
23. Zurawek M, Fichna M, Fichna P, Januszkiewicz D, Nowak J, (2011) No evidence for association of the polymorphisms in NLRP1 gene with type 1 diabetes in Poland. Diabetes Res Clin Pract 92: e49-51.
24. Hu C, Zhang R, Wang C, Ma X, Wang J, et al. (2011) Lack of association between genetic polymorphisms within DUSP12- ATF6 locus and glucose metabolism related traits in a Chinese population. BMC Med Genet 12: 3.
25. Pontillo A, Brandao L, Guimaraes R, Segat L, Araujo J, et al. (2010) Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil. Autoimmunity 43: 583-589.
26. Altinova AE, Engin D, Akbay E, Akturk M, Toruner F, et al. (2010) Association of polymorphisms in the IL-18 and IL-12 genes with susceptibility to Type 1 diabetes in Turkish patients. J Endocrinol Invest 33: 451-454.
27. Qiao Y, Liu R, Tian HM, Liu Y, Qiang O, et al. (2008) [Association of apolipoprotein A5 gene-1131T/C polymorphism with serum lipids and carotid intima-media thickness in patients with type 2 diabetes mellitus]. Sichuan Da Xue Xue Bao Yi Xue Ban 39: 965-968, 999.
28. Wu X, Zhu X, Wang X, Ma J, Zhu S, et al. (2009) Intron polymorphism in the KIAA0350 gene is reproducibly associated with susceptibility to type 1 diabetes (T1D) in the Han Chinese population. Clin Endocrinol (Oxf) 71: 46-49.
29. Li X, Xu Y, Ding Y, Qin C, Dai Z, et al. (2008) Polymorphism of apolipoprotein A5 is a risk factor for cerebral infarction in type 2 diabetes. J Huazhong Univ Sci Technolog Med Sci 28: 653-656.
30. Kawasaki E, Awata T, Ikegami H, Kobayashi T, Maruyama T, et al. (2009) Genetic association between the interleukin-2 receptor-alpha gene and mode of onset of type 1 diabetes in the Japanese population. J Clin Endocrinol Metab 94: 947-952.
31. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, et al. (2008) Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 359: 2767-2777.
32. Magitta NF, Boe Wolff AS, Johansson S, Skinningsrud B, Lie BA, et al. (2009) A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun 10: 120-124.
33. Daimon M, Sato H, Sasaki S, Toriyama S, Emi M, et al. (2008) Salt consumption-dependent association of the GNB3 gene polymorphism with type 2 DM. Biochem Biophys Res Commun 374: 576-580.
34. Ma L, Hanson RL, Que LN, Mack JL, Franks PW, et al. (2008) Association analysis of Kruppel-like factor 11 variants with type 2 diabetes in Pima Indians. J Clin Endocrinol Metab 93: 3644-3649.
35. Tanahashi T, Shinohara K, Keshavarz P, Yamaguchi Y, Miyawaki K, et al. (2008) The association of genetic variants in Kruppel-like factor 11 and Type 2 diabetes in the Japanese population. Diabet Med 25: 19-26.
36. Sparso T, Hussain MS, Borch-Johnsen K, Jorgensen T, Madsbad S, et al. (2007) Studies of association of the CASQ1 rs2275703 polymorphism in relation to type 2 diabetes and related quantitative metabolic traits among 7,088 Danish whites. Mol Genet Metab 92: 278-282.
37. Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, et al. (2007) Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet 39: 1074-1082.
38. Hakonarson H, Grant SF, Bradfield JP, Marchand L, Kim CE, et al. (2007) A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 448: 591-594.
39. Zhai GH, Wen P, Guo LF, Chen L, (2007) [Association of apolipoprotein A5 gene-1131T/C polymorphism with lipid metabolism and insulin resistance in patients with type II diabetes mellitus]. Yi Chuan 29: 541-546.
40. Meex SJ, van Greevenbroek MM, Ayoubi TA, Vlietinck R, van Vliet-Ostaptchouk JV, et al. (2007) Activating transcription factor 6 polymorphisms and haplotypes are associated with impaired glucose homeostasis and type 2 diabetes in Dutch Caucasians. J Clin Endocrinol Metab 92: 2720-2725.
41. Chu WS, Das SK, Wang H, Chan JC, Deloukas P, et al. (2007) Activating transcription factor 6 (ATF6) sequence polymorphisms in type 2 diabetes and pre-diabetic traits. Diabetes 56: 856-862.
42. Hayakawa T, Takamura T, Abe T, Kaneko S, (2007) Association of the C825T polymorphism of the G-protein beta3 subunit gene with hypertension, obesity, hyperlipidemia, insulin resistance, diabetes, diabetic complications, and diabetic therapies among Japanese. Metabolism 56: 44-48.
43. Florez JC, Saxena R, Winckler W, Burtt NP, Almgren P, et al. (2006) The Kruppel-like factor 11 (KLF11) Q62R polymorphism is not associated with type 2 diabetes in 8,676 people. Diabetes 55: 3620-3624.
44. Talmud PJ, Cooper JA, Hattori H, Miller IP, Miller GJ, et al. (2006) The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. Diabetologia 49: 2337-2340.
45. Lin WH, Chuang LM, Chen CH, Yeh JI, Hsieh PS, et al. (2006) Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population. Diabetologia 49: 1214-1221.
46. Thameem F, Farook VS, Bogardus C, Prochazka M, (2006) Association of amino acid variants in the activating transcription factor 6 gene (ATF6) on 1q21-q23 with type 2 diabetes in Pima Indians. Diabetes 55: 839-842.
47. Bento JL, Bowden DW, Mychaleckyj JC, Hirakawa S, Rich SS, et al. (2005) Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes. BMC Med Genet 6: 42.
48. Andersen G, Overgaard J, Albrechtsen A, Glumer C, Borch-Johnsen K, et al. (2006) Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes. Diabetologia 49: 75-82.
49. Santiago JL, Martinez A, de La Calle H, Fernandez-Arquero M, de La Concha EG, et al. (2005) Th1 cytokine polymorphisms in spanish patients with type 1 diabetes. Hum Immunol 66: 897-902.
50. Yan SK, Cheng XQ, Song YH, Xiao XH, Bi N, et al. (2005) Apolipoprotein A5 gene polymorphism-1131T->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese. Clin Chem Lab Med 43: 607-612.
51. Mohlke KL, Skol AD, Scott LJ, Valle TT, Bergman RN, et al. (2005) Evaluation of SLC2A10 (GLUT10) as a candidate gene for type 2 diabetes and related traits in Finns. Mol Genet Metab 85: 323-327.
52. Kiani JG, Saeed M, Parvez SH, Frossard PM, (2005) Association of G-protein beta-3 subunit gene (GNB3) T825 allele with Type II diabetes. Neuro Endocrinol Lett 26: 87-88.
53. Neve B, Fernandez-Zapico ME, Ashkenazi-Katalan V, Dina C, Hamid YH, et al. (2005) Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. Proc Natl Acad Sci U S A 102: 4807-4812.
54. Das SK, Chu W, Zhang Z, Hasstedt SJ, Elbein SC, (2004) Calsquestrin 1 (CASQ1) gene polymorphisms under chromosome 1q21 linkage peak are associated with type 2 diabetes in Northern European Caucasians. Diabetes 53: 3300-3306.
55. Fu M, Damcott CM, Sabra M, Pollin TI, Ott SH, et al. (2004) Polymorphism in the calsequestrin 1 (CASQ1) gene on chromosome 1q21 is associated with type 2 diabetes in the old order Amish. Diabetes 53: 3292-3299.
56. McCormack RM, Maxwell AP, Carson DJ, Patterson CC, Middleton D, et al. (2002) The IL12B 3′ untranslated region DNA polymorphism is not associated with early-onset type 1 diabetes. Genes Immun 3: 433-435.
57. Nistico L, Giorgi G, Giordano M, Galgani A, Petrone A, et al. (2002) IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study. Diabetes 51: 1649-1650.
58. Jiang H, Sun MW, Hefright B, Chen W, Lu CD, et al. (2011) Efficacy of hypocaloric parenteral nutrition for surgical patients: a systematic review and meta-analysis. Clin Nutr 30: 730-737.
59. Coory MD (2010) Comment on: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 39: 932; author reply 933.
60. Ritvo RA, (1987) Coordinating in-patient and out-patient services: the need for action. Soc Work Health Care 13: 39-56.
61. Dowling JK, O'Neill LA, (2012) Biochemical regulation of the inflammasome. Crit Rev Biochem Mol Biol 47: 424-443.
62. Schroder K, Tschopp J, (2010) The inflammasomes. Cell 140: 821-832.
63. Martinon F, Mayor A, Tschopp J, (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27: 229-265.
64. Garg G, Tyler JR, Yang JH, Cutler AJ, Downes K, et al. (2012) Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function. J Immunol 188: 4644-4653.
65. Aminkeng F, Weets I, Van Autreve JE, Koeleman BP, Quartier E, et al. (2010) Association of IL-2RA/CD25 with type 1 diabetes in the Belgian population. Hum Immunol 71: 1233-1237.
66. Dendrou CA, Wicker LS, (2008) The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice. J Clin Immunol 28: 685-696.
67. Chistiakov DA, Voronova NV, Chistiakov PA, (2008) The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies. Immunol Lett 118: 1-5.
68. Luopajarvi K, Nieminen JK, Ilonen J, Akerblom HK, Knip M, et al. (2012) Expansion of CD4+CD25+FOXP3+ regulatory T cells in infants of mothers with type 1 diabetes. Pediatr Diabetes 13: 400-407.
69. Lawson JM, Tremble J, Dayan C, Beyan H, Leslie RD, et al. (2008) Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes. Clin Exp Immunol 154: 353-359.
70. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, et al. (2011) Selective IgA deficiency in autoimmune diseases. Mol Med 17: 1383-1396.
71. Martinez A, Perdigones N, Cenit MC, Espino L, Varade J, et al. (2010) Chromosomal region 16p13: further evidence of increased predisposition to immune diseases. Ann Rheum Dis 69: 309-311.
72. Banos R, Botella C, Garcia-Palacios A, Villa H, Perpina C, et al. (1999) Psychological variables and reality judgment in virtual environments: the roles of absorption and dissociation. Cyberpsychol Behav 2: 143-148.
73. Mero IL, Ban M, Lorentzen AR, Smestad C, Celius EG, et al. (2011) Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus. Genes Immun 12: 191-198.
74. Nowak M, Helleboid-Chapman A, Jakel H, Moitrot E, Rommens C, et al. (2008) Glucose regulates the expression of the apolipoprotein A5 gene. J Mol Biol 380: 789-798.
75. Pruneta-Deloche V, Ponsin G, Groisne L, Fruchart-Najib J, Lagarde M, et al. (2005) Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patients. Atherosclerosis 181: 403-405.
76. Jakel H, Nowak M, Helleboid-Chapman A, Fruchart-Najib J, Fruchart JC, (2006) Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins? Ann Med 38: 2-10.
77. Garelnabi M, Lor K, Jin J, Chai F, Santanam N, (2013) The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research. Clin Biochem 46: 12-19.
78. Soter MO, Gomes KB, Fernandes AP, Carvalho M, Pinheiro PS, et al. (2012) -1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients. Mol Biol Rep 39: 7541-7548.
79. Esteve E, Faure E, Calvo F, Aguillo E, Blasco C, et al. (2004) SNP3 polymorphism in apo A-V gene is associated with small dense LDL particles in Type 2 diabetes. Diabetologia 47: 355-356.
80. Bhaskar S, Ganesan M, Chandak GR, Mani R, Idris MM, et al. (2011) Association of PON1 and APOA5 gene polymorphisms in a cohort of Indian patients having coronary artery disease with and without type 2 diabetes. Genet Test Mol Biomarkers 15: 507-512.
81. Charriere S, Bernard S, Aqallal M, Merlin M, Billon S, et al. (2008) Association of APOA5-1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients. Clin Chim Acta 394: 99-103.
82. Grarup N, Andersen G, (2007) Gene-environment interactions in the pathogenesis of type 2 diabetes and metabolism. Curr Opin Clin Nutr Metab Care 10: 420-426.
83. Jiang YD, Yen CJ, Chou WL, Kuo SS, Lee KC, et al. (2005) Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in Type 2 diabetic subjects. Diabet Med 22: 1690-1695.
84. Hiramatsu M, Oguri M, Kato K, Horibe H, Fujimaki T, et al. (2012) Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome. Int J Mol Med 30: 185-192.
85. Dorfmeister B, Cooper JA, Stephens JW, Ireland H, Hurel SJ, et al. (2007) The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes. Biochim Biophys Acta 1772: 355-363.
86. Chandak GR, Ward KJ, Yajnik CS, Pandit AN, Bavdekar A, et al. (2006) Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans. BMC Med Genet 7: 76.